Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy Integration
NCT06762379 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 125
Last updated 2026-03-24
Summary
Implementation of a new algorithm for HRR gene mutation testing in patients with mPC through liquid biopsy integration
Conditions
- Metastatic Prostate Cancer (mPC)
Sponsors & Collaborators
- collaborator INDUSTRY
-
European Institute of Oncology
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-20
- Primary Completion
- 2027-12-31
- Completion
- 2030-12-31
Countries
- Italy
Study Locations
More Related Trials
-
All-in-One Prostate Cancer Staging with MRI
NCT06071195 ·Status: RECRUITING
-
Evaluation of a Multimodal Strategy for Early Diagnosis of Men at High Genetic Risk of Prostate Cancer
NCT05333432 ·Status: WITHDRAWN ·Phase: NA
-
PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study
NCT05806853 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand
NCT04266392 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Biological Markers and Advanced Imaging for Prostate Cancer Progression in Active Surveillance
NCT06866041 ·Status: RECRUITING ·Phase: NA
-
INSIDE: Identification of Genomic Screening Pathways in Cancer Patients With DNA Repair Alterations
NCT06334809 ·Status: RECRUITING
-
Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer
NCT04702633 ·Status: COMPLETED
-
Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance
NCT02526797 ·Status: ENROLLING_BY_INVITATION
-
Genetic Biomarker Discovery for Metastatic Prostate Cancer
NCT03228810 ·Status: COMPLETED
-
A Single-center Prospective Interventional Study on FPG500 in Non-metastatic Prostate Cancer Patients
NCT06875297 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
NCT04692675 ·Status: RECRUITING ·Phase: NA
-
F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer
NCT00963755 ·Status: COMPLETED
-
Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR
NCT03149861 ·Status: COMPLETED ·Phase: NA
-
Artificial Intelligence-based Platform, Integrating Pathologic, Imaging and Molecular Profiles of Prostate Cancer
NCT06468332 ·Status: RECRUITING
-
Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers
NCT03585114 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Prostate Oligometastatic Cancer Management Driven by Disease Biology et/or Immunoactivity (PROMETEO)
NCT06060652 ·Status: RECRUITING
-
PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer
NCT03768349 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Prostate Cancer Prevention Clinic for Men With Risk of Familial Prostate Cancer
NCT05681416 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Detection and Localization of Carcinoma Using High Resolution Transrectal Imaging - Proof of Concept Study
NCT02786459 ·Status: COMPLETED ·Phase: NA
-
Prostate HistoScanning for the Non-invasive Detection and Staging of Prostate Cancer and Characterization of Prostate Tissues (PHS-02)
NCT01191931 ·Status: COMPLETED
-
Biparametric MRI for Detection of Significant Prostate Cancer
NCT02584179 ·Status: COMPLETED ·Phase: NA
-
PRostate Cancer Plasma Integrative Multi-modal Evaluation
NCT06981377 ·Status: RECRUITING
-
Prostate Cancer Screening With Abbreviated MRI Protocol
NCT05603351 ·Status: RECRUITING ·Phase: NA
-
Precision-Based Genomics in Prostate Cancer
NCT04706663 ·Status: RECRUITING
-
Hypofractionated Intensity Modulated Radiation Therapy Plus Hormonal Therapy in Patients With High Risk Prostate Cancer
NCT02107287 ·Status: COMPLETED ·Phase: NA